CrowdStrike Announces Launch of Endpoint Protection Complete
CrowdStrike® Inc., the leader in cloud-delivered endpoint protection, today announced the launch of CrowdStrike Falcon® Endpoint Protection Complete™, a turnkey solution, combining the Falcon Endpoint Protection (EPP) technology with the skills and experience of the Falcon Endpoint Protection Team. Falcon Endpoint Protection Complete changes the game by making endpoint security powerful and easy for all organizations, regardless of their current security posture. This new solution further completes the CrowdStrike portfolio and enables CrowdStrike partners to offer a comprehensive gamut of endpoint security options to their customers.
The EPP Complete solution combines the effectiveness of the Falcon platform with the efficiency of a dedicated team of security professionals. It unifies the technology, people, processes and expertise to handle all aspects of endpoint security — from deployment, configuration and maintenance to monitoring, alert handling and remediation. CrowdStrike EPP Complete uniquely integrates powerful best-in-class prevention, detection and response with IT hygiene capabilities, coupled with the Falcon EPP team of security experts, to provide a powerful defense against the rapidly changing tactics, techniques and procedures (TTPs) used by adversaries. This scalable solution offers organizations of all sizes the highest level of endpoint security possible.
According to Gartner, “Many customers lacked the skill sets to leverage the emerging security technologies they had purchased, so offering MDR services was a way for product vendors to help customers utilize their technology fully.”*
“With the launch of EPP Complete, CrowdStrike is demonstrating our continued industry leadership and commitment to delivering the most comprehensive and effective combination of technology, services and intelligence to stop breaches and help businesses stay focused on their work,” said George Kurtz, CrowdStrike’s co-founder and chief executive officer. “We are enabling customers to solve challenges related to security staffing and resources by allowing them to multiply their capacity to manage and respond to alerts and to take full advantage of their technology investments.”
“Assessing a company’s business requirements first, and starting with an ‘inside-out’ view on risk, can identify and prioritize gaps in security program execution across tools and processes,” said Todd Weber, vice president of Partner Research and Strategy for Optiv. “Combining Optiv’s approach and expertise with CrowdStrike’s continued commitment to address modern threats helps organizations effectively assess and address current and future threats, so they can take appropriate action to maintain the proper risk posture.”
“With this latest launch, CrowdStrike continues to demonstrate its ability to offer a complete security solution of both technology and services to our customers,” said president Ikeda of Macnica Networks Corp. “As a security solution provider, it is vital to our continued success to be able to partner with cutting-edge organizations that can address customer needs in a multitude of markets to better secure critical data and infrastructure.”
“CrowdStrike continues to innovate its full suite of security technology and services offerings to give our joint customers the most comprehensive endpoint protection capabilities available,” says Steven Robb, president of the Solutions Group at LaSalle Solutions. “Our partnership with CrowdStrike provides our customers with solutions to optimize technology operations and secure critical data in the ever-changing IT landscape.”
For more information about CrowdStrike’s Spring Platform launch, read a blog by George Kurtz, CrowdStrike’s CEO, here.
Visit CrowdStrike during the RSA Conference 2018 at booth #941 Moscone South to see presentations and demos and meet with our experts.
*Gartner: What MSSPs Need to Know About Offering MDR Services, Sid Deshpande, Craig Lawson, Toby Bussa, Kelly M. Kavanagh, 03 January 2018.
CrowdStrike is the leader in cloud-delivered endpoint protection. Leveraging artificial intelligence (AI), the CrowdStrike Falcon® platform offers instant visibility and protection across the enterprise and prevents attacks on endpoints on or off the network. CrowdStrike Falcon deploys in minutes to deliver actionable intelligence and real-time protection from Day One. It seamlessly unifies next-generation AV with best-in-class endpoint detection and response, backed by 24/7 managed hunting. Its cloud infrastructure and single-agent architecture take away complexity and add scalability, manageability, and speed.
CrowdStrike Falcon protects customers against all cyber attack types, using sophisticated signatureless AI and Indicator-of-Attack (IOA) based threat prevention to stop known and unknown threats in real time. Powered by the CrowdStrike Threat Graph™, Falcon instantly correlates over 100 billion security events a day from across the globe to immediately prevent and detect threats.
There’s much more to the story of how Falcon has redefined endpoint protection but there’s only one thing to remember about CrowdStrike: We stop breaches.
You can gain full access to CrowdStrike Falcon Prevent™ by starting your free trial here.
© 2018 CrowdStrike, Inc. All rights reserved. CrowdStrike®, CrowdStrike Falcon®, CrowdStrike Threat Graph™, CrowdStrike Falcon Prevent™, Falcon Prevent™, CrowdStrike Falcon Insight™, Falcon Insight™, CrowdStrike Falcon Discover™, Falcon Discover™, CrowdStrike Falcon Intelligence™, Falcon Intelligence™, CrowdStrike Falcon DNS™, Falcon DNS™, CrowdStrike Falcon OverWatch™, Falcon OverWatch™, CrowdStrike Falcon Spotlight™ and Falcon Spotlight™ are among the trademarks of CrowdStrike, Inc. Other brands may be third-party trademarks.
Ilina Cashiola, 202-340-0517
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Manchester United and True Religion Launch Denim Range19.10.2018 20:37 | Tiedote
Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion
Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10 | Tiedote
Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr
Tradeshift Announces Q3 2018 Results19.10.2018 14:00 | Tiedote
Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between
Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00 | Tiedote
Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme